EUVIMEDEUVIMED entdecken
Crossref

Ultrasound‐Triggered Diselenide Bonds Scission for On‐Demand Drug Release in Osteoarthritis Therapy

Meijun Zhou, Yanni He, Ning Zhang, Jianwei Yang, Honghui Weng, Renhao Xu, Lizhen He, Tianfeng Chen, Hongmei Liu

Advanced Functional Materials · 2026-04 · 36 (35)

DOI: 10.1002/adfm.202527134 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Functional Materials, online erschienen am 24.01.2026. Verfasst von Meijun Zhou und 8 weiteren Autor:innen. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 65 Literaturangaben. Gefördert von: National Science Fund for Distinguished Young Scholars, National Natural Science Foundation of China, Natural Science Foundation of Guangdong Province.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Disruption of chondrocyte redox homeostasis is a critical pathogenic factor in osteoarthritis (OA). Selenium (Se), an essential trace element, helps maintain redox balance by regulating 25 selenoproteins in human tissues. Based on this, we developed a Se‐based OA treatment strategy using a novel ultrasound‐responsive hydrogel (HA‐Se hydrogel). This system employs hyaluronic acid (HA) as a matrix and integrates ultrasound‐responsive diselenide (Se─Se) bonds that act as an intelligent “on‐off” for precise spatiotemporal control of Se release at the lesion site. This promotes efficient conversion into bioactive selenoproteins, restoring redox homeostasis in the OA microenvironment. In vitro and in vivo results demonstrate that ultrasound‐triggered scission of Se─Se bonds facilitates on‐demand Se release. The released Se is converted into selenoproteins, which enhance antioxidant capacity, reduce ROS accumulation, and restore mitochondrial membrane potential, thereby inhibiting chondrocyte apoptosis, attenuating inflammation, and delaying OA progression. Furthermore, this system enhances SOX9 expression by activating the PI3K/AKT pathway, thereby activating COL2A1 and inhibiting MMP13 to regulate cartilage metabolism balance. In conclusion, the engineered HA‐Se hydrogel provides an effective solution for achieving controlled Se release in OA therapy. It represents a multi‐target treatment strategy combining anti‐oxidation, anti‐apoptosis, anti‐inflammation, and anti‐metabolic mechanisms, with significant clinical translation potential.

Förderung

  • National Science Fund for Distinguished Young Scholars
  • National Natural Science Foundation of China
  • Natural Science Foundation of Guangdong Province

Zitieren

APA

Zhou, M., He, Y., Zhang, N., Yang, J., Weng, H., Xu, R., He, L., Chen, T., & Liu, H. (2026). Ultrasound‐Triggered Diselenide Bonds Scission for On‐Demand Drug Release in Osteoarthritis Therapy. Advanced Functional Materials, 36(35). https://doi.org/10.1002/adfm.202527134

Vancouver

Zhou M, He Y, Zhang N, Yang J, Weng H, Xu R, et al. Ultrasound‐Triggered Diselenide Bonds Scission for On‐Demand Drug Release in Osteoarthritis Therapy. Advanced Functional Materials. 2026;36(35). doi:10.1002/adfm.202527134

BibTeX
@article{Zhou2026,
  author = {Zhou, Meijun and He, Yanni and Zhang, Ning and Yang, Jianwei and Weng, Honghui and Xu, Renhao and He, Lizhen and Chen, Tianfeng and Liu, Hongmei},
  title = {Ultrasound‐Triggered Diselenide Bonds Scission for On‐Demand Drug Release in Osteoarthritis Therapy},
  journal = {Advanced Functional Materials},
  year = {2026},
  volume = {36},
  number = {35},
  doi = {10.1002/adfm.202527134}
}
Kostenlos starten →